%0 Journal Article %A Nadia Milad %A Mathieu C. Morissette %T Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure %D 2021 %R 10.1183/16000617.0077-2021 %J European Respiratory Review %P 210077 %V 30 %N 162 %X Pulmonary surfactant is a crucial and dynamic lung structure whose primary functions are to reduce alveolar surface tension and facilitate breathing. Though disruptions in surfactant homeostasis are typically thought of in the context of respiratory distress and premature infants, many lung diseases have been noted to have significant surfactant abnormalities. Nevertheless, preclinical and clinical studies of pulmonary disease too often overlook the potential contribution of surfactant alterations – whether in quantity, quality or composition – to disease pathogenesis and symptoms. In inflammatory lung diseases, whether these changes are cause or consequence remains a subject of debate. This review will outline 1) the importance of pulmonary surfactant in the maintenance of respiratory health, 2) the diseases associated with primary surfactant dysregulation, 3) the surfactant abnormalities observed in inflammatory pulmonary diseases and, finally, 4) the available research on the interplay between surfactant homeostasis and smoking-associated lung disease. From these published studies, we posit that changes in surfactant integrity and composition contribute more considerably to chronic inflammatory pulmonary diseases and that more work is required to determine the mechanisms underlying these alterations and their potential treatability.Pulmonary surfactant is a crucial structure for lung function and gas exchange. Recent studies have documented pulmonary surfactant abnormalities in most chronic lung diseases, participating in disease pathology and symptoms. https://bit.ly/3CSaXeK %U https://err.ersjournals.com/content/errev/30/162/210077.full.pdf